Sign in
Active, not recruitingNo phase

RETHINK REFLUX Registry

Key facts

Who runs it
Ethicon Endo-Surgery
Where
Allentown, Amarillo, Appleton, Columbus, Edgewood, Englewood, Greenville, Greenwood, Houston, Lancaster, Lansing, Los Angeles, Mobile, Peoria, Richmond, San Antonio, Seattle, Tampa, Tucson, and West Columbia, United StatesSee the 21 sitesAlso in 5 other countries, 7 sites
Trial code
Status
Active, not recruiting
People taking part
500 people enrolled
Started
8 Jul 2020
Expected to end
31 Jul 2032
Type of study
Observational
Treatments tested
  • LINX Reflux Management System
Record updated
3 November 2026

Who can take part

Age
21 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Subject is >or=21 years old
  • Subject with prospective plans for a LINX procedure
  • Subject provides written informed consent
  • Subject must be willing and able to complete questionnaires/ surveys electronically (ePROs)

Who cannot take part

  • Subject who was previously implanted with LINX device
  • Any reason which the Principal Investigator believes may cause the subject to be non-compliant with or unable to meet the protocol requirements (i.e. medical illness and/or limited life expectancy of less than 10 years); Note: Physicians should refer to the LINX Reflux Management System IFU for a complete list of contraindications, warnings, and precautions

Where in United States

Also in 5 other countries, 7 sites

  • Lehigh Valley Hospital-Cedar CrestAllentown, United States
  • Panhandle Weight Loss CenterAmarillo, United States
  • Fox Valley Surgical AssociatesAppleton, United States
  • The Ohio State UniversityColumbus, United States
  • Saint Elizabeth Healthcare EdgewoodEdgewood, United States
  • Institute of Esophageal and Reflux SurgeryEnglewood, United States
  • East Carolina University / Vidant Medical CenterGreenville, United States
  • Minimal Access Surgery/Prisma Health - UpstateGreenville, United States
  • Adv Surg Assoc / Self Regional HealthcareGreenwood, United States
  • Houston MethodistHouston, United States
  • Gen Surg Assoc / Fairfield Medical CenterLancaster, United States
  • Sparrow Hospital / Sparrow Medical GroupLansing, United States
  • Keck Hospital of USCLos Angeles, United States
  • University of South AlabamaMobile, United States
  • OSF Medical GroupPeoria, United States
  • Richmond Surg / Henrico Doctors' HospitalRichmond, United States
  • Bariatric Medical Institute of TexasSan Antonio, United States
  • Swedish Medical CenterSeattle, United States
  • University of Southern Florida (Tampa General Hospital)Tampa, United States
  • NW Allied Bariatric and Foregut SurgeryTucson, United States
  • Lexington SurgeryWest Columbia, United States

About the trial

What the trial wants to find out

The RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. The primary objective of the study is to confirm the long-term safety profile of the LINX device and procedure (implant/explant) up to 10 years post-implant.

Treatments tested

  • LINX Reflux Management System

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Research to Further Inform Thinking About the Role of LINX for Reflux Disease
Record updated
3 November 2026